SecurityRWJ / RevenueShares ETF (68386C302)
Institutional Owners54
Institutional Shares3,678,574
Institutional Value$ 289,019,000 USD

Institutional Stock Ownership and Shareholders

RevenueShares ETF (NYSE:RWJ) has 54 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3,678,574 shares. Largest shareholders include Morgan Stanley, Bank Of America Corp /de/, Commonwealth Equity Services, Llc., Wells Fargo & Company/mn, Commonwealth Equity Services, Inc, LPL Financial LLC, Raymond James Financial Services Advisors, Inc., Royal Bank Of Canada, Fusion Family Wealth LLC, and Raymond James & Associates.
RevenueShares ETF (NYSE:RWJ) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-14 13F-HR Commonwealth Equity Services, Llc. 400,233 328,590 -17.90 27,968 22,281 -20.33
2018-05-14 13F-HR AMERIPRISE FINANCIAL INC 53,133 53,263 0.24 3,711 3,610 -2.72
2018-05-10 13F-HR Stratos Wealth Partners, LTD. 3,299 4,848 46.95 231 329 42.42
2018-04-18 13F-HR REGIONS FINANCIAL CORP 21 0 -100.00 1 0 -100.00
2018-05-11 13F-HR CITIGROUP INC 2,652 2,632 -0.75 185 178 -3.78
2018-05-15 13F-HR JANE STREET GROUP, LLC 39,923 22,745 -43.03 2,790 1,542 -44.73
2018-05-09 13F-HR IFP Advisors, Inc 14,491 15,223 5.05 1,013 1,032 1.88
2018-05-11 13F-HR STIFEL FINANCIAL CORP 5,295 5,238 -1.08 368 355 -3.53
2018-02-14 13F-HR MORGAN STANLEY 718,093 711,910 -0.86 49,204 49,748 1.11
2018-05-10 13F-HR FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. 4,239 4,315 1.79 296 293 -1.01
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 357,841 388,080 8.45 25,006 26,316 5.24
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 14,653 24,825 69.42 1,024 1,684 64.45
2018-05-02 13F-HR Creative Financial Designs Inc /adv 445 30
2018-05-09 13F-HR Cambridge Investment Research Advisors, Inc. 22,285 17,085 -23.33 1,557 1,159 -25.56
2018-04-09 13F-HR BLB&B Advisors, LLC 26,110 26,110 0.00 1,825 1,771 -2.96
2018-05-15 13F-HR Advisor Group, Inc. 47,308 52,523 11.02 3,305 3,561 7.75
2018-04-26 13F-HR Winslow, Evans & Crocker, Inc. 560 560 0.00 39,010 37,930 -2.77
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 54,226 41,147 -24.12 3,789 2,790 -26.37
2018-05-09 13F-HR ENVESTNET ASSET MANAGEMENT INC 200 200 0.00 14 14 0.00
2018-04-20 13F-HR Steward Partners Investment Advisory, Llc 3,205 3,205 0.00 223 217 -2.69
2018-04-26 13F-HR FineMark National Bank & Trust 0 4,603 0 312
2018-05-15 13F-HR Ancora Advisors, LLC 76,227 76,227 0.00 5,327 5,169 -2.97
2018-04-16 13F-HR Horan Securities, Inc. 87 87 0.00 6 6 0.00
2018-05-09 13F-HR Cetera Advisor Networks LLC 20,390 13,099 -35.76 1,425 890 -37.54
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 12,400 4,800 -61.29 867 325 -62.51
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 159,576 163,784 2.64 11,151 11,107 -0.39
2018-04-19 13F-HR Janney Montgomery Scott LLC 15,010 13,537 -9.81 1,049 918 -12.49
2018-04-16 13F-HR SII INVESTMENTS INC/WI 13,594 0 -100.00 947 0 -100.00
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 152,964 171,645 12.21 10,689 11,639 8.89
2018-04-17 13F-HR FIRST FINANCIAL CORP /IN/ 1,025 1,025 0.00 72 70 -2.78
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 267,631 267,531 -0.04 17,672 18,331 3.73
2018-02-14 13F-HR Patriot Financial Group Insurance Agency, LLC 2,403 2,203 -8.32 163 156 -4.29
2018-04-25 13F-HR Klingman & Associates, LLC 11,033 11,233 1.81 771 762 -1.17
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 239,597 142,338 -40.59 16,743 9,652 -42.35
2018-05-08 13F-HR US BANCORP \DE\ 911 911 0.00 64 62 -3.12
2018-02-09 13F-HR FDx Advisors, Inc. 12,843 0 -100.00 880 0 -100.00
2018-04-06 13F-HR Kistler-Tiffany Companies, LLC 800 800 0.00 56 54 -3.57
2018-05-15 13F-HR UBS Group AG 121,512 123,755 1.85 8,491 8,392 -1.17
2018-05-10 13F-HR JP Morgan Chase & Co 17,787 16,703 -6.09 1,243 1,133 -8.85
2018-04-06 13F-HR Carroll Financial Associates, Inc. 32,052 44,227 37.99 2,239 2,999 33.94
2018-04-18 13F-HR Cordasco Financial Network 715 715 0.00 50 48 -4.00
2018-05-11 13F-HR MADISON INVESTMENT HOLDINGS INC 39,127 40,139 2.59 2,734 2,722 -0.44
2018-02-14 13F-HR Krilogy Financial LLC 1,219 0 -100.00 84 0 -100.00
2018-05-02 13F-HR Fusion Family Wealth LLC 132,700 157,481 18.67 9,274 10,679 15.15
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 1 1 0.00 0 0
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 63 63 0.00 4 4 0.00
2018-04-16 13F-HR BALDWIN BROTHERS INC/MA 871 871 0.00 61 59 -3.28
2018-05-09 13F-HR Private Advisor Group, LLC 37,389 59,349 58.73 2,653 4,024 51.68
2018-04-27 13F-HR Hudock Capital Group, LLC 818 821 0.37 57 55 -3.51
2018-04-26 13F-HR TOMPKINS FINANCIAL CORP 64,142 35,552 -44.57 4,481 2,411 -46.20
2018-04-26 13F-HR Ifg Advisory, Llc 12,683 0 -100.00 770 0 -100.00
2018-04-30 13F-HR/A Viridian Ria, Llc 10,482 710
2018-02-09 13F-HR Baird Financial Group, Inc. 5,903 5,903 0.00 404 413 2.23
2018-05-15 13F-HR Ferris Capital, Llc 9 1
2018-02-14 13F-HR GOLDMAN SACHS GROUP INC 13,211 0 -100.00 905 0 -100.00
2018-05-04 13F-HR ARGI Investment Services, LLC 23,815 21,380 -10.22 1,664 1,450 -12.86
2018-04-17 13F-HR BENJAMIN F. EDWARDS & COMPANY, INC. 500 500 0.00 35 34 -2.86
2018-05-07 13F-HR Centaurus Financial, Inc. 3,830 3,942 2.92 268 267 -0.37
2018-05-15 13F-HR LPL Financial LLC 250,812 228,607 -8.85 17,527 15,502 -11.55
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 324,799 319,019 -1.78 22,697 21,633 -4.69
2018-05-14 13F-HR NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 33,866 37,088 9.51 2,366 2,515 6.30

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

14h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

14h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 68386C302